Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Testing effectiveness (Phase 2)UnknownNCT02098720
What this trial is testing

An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Very Low Vision Secondary to Wet Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 30
Early research (Phase 1)Not Yet RecruitingNCT05611424
What this trial is testing

Gene Therapy for Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Frontera Therapeutics 18
Early research (Phase 1)Study completedNCT02022540
What this trial is testing

Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration (AMD)
PanOptica, Inc. 50
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Testing effectiveness (Phase 2)Looking for participantsNCT04504123
What this trial is testing

MMP-9 Inhibition for Recalcitrant Wet AMD

Who this might be right for
Exudative Macular DegenerationWet Age-related Macular Degeneration
University of Iowa 50
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Testing effectiveness (Phase 2)Looking for participantsNCT05986864
What this trial is testing

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Skyline Therapeutics (US) Inc. 68
Post-approval studies (Phase 4)Study completedNCT02161575
What this trial is testing

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 103
Not applicableEnded earlyNCT05038371
What this trial is testing

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Johns Hopkins University 20
Large-scale testing (Phase 3)Study completedNCT05155293
What this trial is testing

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)

Who this might be right for
Neovascular (Wet) AMD
Alvotech Swiss AG 413
Not applicableUnknownNCT05562336
What this trial is testing

Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).

Who this might be right for
Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
Sohag University 2
Testing effectiveness (Phase 2)Study completedNCT03558074
What this trial is testing

Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT02121353
What this trial is testing

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration (AMD)
Pfenex, Inc 25
Testing effectiveness (Phase 2)Looking for participantsNCT07776522
What this trial is testing

Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT01940900
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 627
Large-scale testing (Phase 3)Active Not RecruitingNCT06683742
What this trial is testing

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

Who this might be right for
Wet Age Related Macular DegenerationwAMD
EyePoint Pharmaceuticals, Inc. 400
Not applicableActive Not RecruitingNCT04645212
What this trial is testing

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 23
Not applicableEnded earlyNCT03699618
What this trial is testing

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Submacular HemorrhageWet Macular DegenerationNeovascular Age-related Macular Degeneration
Johns Hopkins University 1
Next Page